<![CDATA[Chugai Pharmaceutical: News Releases]]> https://www.chugai-pharm.co.jp/english/index.html en-us Fri, 24 Apr 2026 17:00:01 +0900 <![CDATA[Organizational and Personnel Changes]]> https://www.chugai-pharm.co.jp/english/news/detail/20260424170001_1245.html Fri, 24 Apr 2026 17:00:01 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260424170001_1245.html <![CDATA[Chugai Announces 2026 1st Quarter Results]]> https://www.chugai-pharm.co.jp/english/news/detail/20260424170002_1247.html Fri, 24 Apr 2026 17:00:02 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260424170002_1247.html <![CDATA[Determination of Details Regarding Share Acquisition Associated with the Introduction of the Trust-Based Stock Compensation System]]> https://www.chugai-pharm.co.jp/english/news/detail/20260424170000_1248.html Fri, 24 Apr 2026 17:00:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260424170000_1248.html <![CDATA[F. Hoffmann-La Roche Announces First Quarter Sales 2026]]> https://www.chugai-pharm.co.jp/english/news/detail/20260423140000_1242.html Thu, 23 Apr 2026 14:00:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260423140000_1242.html <![CDATA[FJ3, API Manufacturing Building for Small Molecule and Macrocyclic Peptide Drugs at the Fujieda Plant, Receives the 2026 Facility of the Year Awards from ISPE in the Honorable Mention Category]]> https://www.chugai-pharm.co.jp/english/news/detail/20260422163000_1243.html Wed, 22 Apr 2026 16:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260422163000_1243.html <![CDATA[Roche’s Announcement Regarding New Data of Enspryng for Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)]]> https://www.chugai-pharm.co.jp/english/news/detail/20260422153000_1246.html Wed, 22 Apr 2026 15:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260422153000_1246.html <![CDATA[Chugai Selected as “Digital Transformation Stocks (DX Stocks) 2026”]]> https://www.chugai-pharm.co.jp/english/news/detail/20260410170000_1241.html Fri, 10 Apr 2026 17:00:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260410170000_1241.html <![CDATA[Announcement of Termination of Co-Promotion of Rituxan® in Japan (Anti-CD20 Monoclonal Antibody)]]> https://www.chugai-pharm.co.jp/english/news/detail/20260409153000_1239.html Thu, 09 Apr 2026 15:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260409153000_1239.html <![CDATA[Research Results on Immune Thrombocytopenia from a Joint Study with Osaka University’s IFReC Published in Blood]]> https://www.chugai-pharm.co.jp/english/news/detail/20260406153000_1240.html Mon, 06 Apr 2026 15:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260406153000_1240.html <![CDATA[Lilly’s Announcement Regarding Oral GLP-1 Foundayo™ (Orforglipron)]]> https://www.chugai-pharm.co.jp/english/news/detail/20260402083000_1238.html Thu, 02 Apr 2026 08:30:00 +0900 https://www.chugai-pharm.co.jp/english/news/detail/20260402083000_1238.html